Search for Clinical Trial Results

Progressive Familial Intrahepatic Cholestasis 1 - 9 Studies Found
Status | Study |
No longer available |
Study Name: Buphenyl Therapy for Byler's Disease Condition: Byler Disease Date: 2013-02-04 Interventions: Drug: Buphenyl |
No longer available |
Study Name: Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease Condition: Byler Disease Date: 2013-09-20 Interventions: Drug: Glycerol phenylbutyrate Other Name: RAVICTI |
Temporarily not available |
Study Name: Expanded Access Protocol for an Intermediate Size Population - RAVICTI for Byler Disease Condition: Byler Disease Date: 2014-03-19 Interventions: Drug: RAVICTI open label expanded access protocol of titrated dosing regimen of RAVICTI for up to 60 wee |
Active, not recruiting |
Study Name: Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis Condition: Progressive Familial Intrahepatic Cholestasis (PFIC) Date: 2014-02-05 Interventions: Drug: LUM001 LUM001 oral dose |
Completed |
Study Name: Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease Condition:
|
Completed |
Study Name: An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects Condition:
|
Completed |
Study Name: A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384 Condition:
|
Completed |
Study Name: Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases Condition: Hepatobiliary Diseases Date: 2010-08-31 |
Recruiting |
Study Name: Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC) Condition:
|